189 related articles for article (PubMed ID: 24352446)
41. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.
Jinushi M; Takehara T; Tatsumi T; Kanto T; Miyagi T; Suzuki T; Kanazawa Y; Hiramatsu N; Hayashi N
J Immunol; 2004 Nov; 173(10):6072-81. PubMed ID: 15528343
[TBL] [Abstract][Full Text] [Related]
42. Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells.
Bedel R; Thiery-Vuillemin A; Grandclement C; Balland J; Remy-Martin JP; Kantelip B; Pallandre JR; Pivot X; Ferrand C; Tiberghien P; Borg C
Cancer Res; 2011 Mar; 71(5):1615-26. PubMed ID: 21257710
[TBL] [Abstract][Full Text] [Related]
43. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
Song H; Kim J; Cosman D; Choi I
Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
[TBL] [Abstract][Full Text] [Related]
44. Role of Polymorphisms of NKG2D Receptor and Its Ligands in Acute Myeloid Leukemia and Human Stem Cell Transplantation.
Machuldova A; Holubova M; Caputo VS; Cedikova M; Jindra P; Houdova L; Pitule P
Front Immunol; 2021; 12():651751. PubMed ID: 33868289
[TBL] [Abstract][Full Text] [Related]
45. The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack.
Dassa L; Seidel E; Oiknine-Djian E; Yamin R; Wolf DG; Le-Trilling VTK; Mandelboim O
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950412
[TBL] [Abstract][Full Text] [Related]
46. Detection and significance of cytotoxic cell subsets in biopsies of HCV-infected human livers.
Mozer-Lisewska I; Mania A; Kowala-Piaskowska A; Kluk A; Samara H; Pauli A; Żeromski J
Arch Immunol Ther Exp (Warsz); 2014 Apr; 62(2):153-60. PubMed ID: 24232187
[TBL] [Abstract][Full Text] [Related]
47. Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance.
Alter G; Jost S; Rihn S; Reyor LL; Nolan BE; Ghebremichael M; Bosch R; Altfeld M; Lauer GM
J Hepatol; 2011 Aug; 55(2):278-88. PubMed ID: 21168454
[TBL] [Abstract][Full Text] [Related]
48. Cytokine-activated natural killer cells exert direct killing of hepatoma cells harboring hepatitis C virus replicons.
Larkin J; Bost A; Glass JI; Tan SL
J Interferon Cytokine Res; 2006 Dec; 26(12):854-65. PubMed ID: 17238828
[TBL] [Abstract][Full Text] [Related]
49. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications.
Jimenez-Perez MI; Jave-Suarez LF; Ortiz-Lazareno PC; Bravo-Cuellar A; Gonzalez-Ramella O; Aguilar-Lemarroy A; Hernandez-Flores G; Pereira-Suarez AL; Daneri-Navarro A; del Toro-Arreola S
BMC Immunol; 2012 Feb; 13():7. PubMed ID: 22316211
[TBL] [Abstract][Full Text] [Related]
50. MICA SNPs and the NKG2D system in virus-induced HCC.
Goto K; Kato N
J Gastroenterol; 2015 Mar; 50(3):261-72. PubMed ID: 25270965
[TBL] [Abstract][Full Text] [Related]
51. Complement Regulation and Immune Evasion by Hepatitis C Virus.
Kwon YC; Ray R
Methods Mol Biol; 2019; 1911():337-347. PubMed ID: 30593637
[TBL] [Abstract][Full Text] [Related]
52. Analysis of hepatitis C virus core/NS5A protein co-localization using novel cell culture systems expressing core-NS2 and NS5A of genotypes 1-7.
Galli A; Scheel TKH; Prentoe JC; Mikkelsen LS; Gottwein JM; Bukh J
J Gen Virol; 2013 Oct; 94(Pt 10):2221-2235. PubMed ID: 23907394
[TBL] [Abstract][Full Text] [Related]
53. Interleukin 10 decreases MICA expression on melanoma cell surface.
Serrano AE; Menares-Castillo E; Garrido-Tapia M; Ribeiro CH; Hernández CJ; Mendoza-Naranjo A; Gatica-Andrades M; Valenzuela-Diaz R; Zúñiga R; López MN; Salazar-Onfray F; Aguillón JC; Molina MC
Immunol Cell Biol; 2011 Mar; 89(3):447-57. PubMed ID: 20714339
[TBL] [Abstract][Full Text] [Related]
54. Hepatitis C virus infection downregulates the ligands of the activating receptor NKG2D.
Wen C; He X; Ma H; Hou N; Wei C; Song T; Zhang Y; Sun L; Ma Q; Zhong H
Cell Mol Immunol; 2008 Dec; 5(6):475-8. PubMed ID: 19118515
[TBL] [Abstract][Full Text] [Related]
55. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein.
Wu J; Chalupny NJ; Manley TJ; Riddell SR; Cosman D; Spies T
J Immunol; 2003 Apr; 170(8):4196-200. PubMed ID: 12682252
[TBL] [Abstract][Full Text] [Related]
56. Transcriptional repression of C4 complement by hepatitis C virus proteins.
Banerjee A; Mazumdar B; Meyer K; Di Bisceglie AM; Ray RB; Ray R
J Virol; 2011 May; 85(9):4157-66. PubMed ID: 21345967
[TBL] [Abstract][Full Text] [Related]
57. Cytoplasmic Citrate Flux Modulates the Immune Stimulatory NKG2D Ligand MICA in Cancer Cells.
Møller SH; Mellergaard M; Madsen M; Bermejo AV; Jepsen SD; Hansen MH; Høgh RI; Aldana BI; Desler C; Rasmussen LJ; Sustarsic EG; Gerhart-Hines Z; Daskalaki E; Wheelock CE; Hiron TK; Lin D; O'Callaghan CA; Wandall HH; Andresen L; Skov S
Front Immunol; 2020; 11():1968. PubMed ID: 32849657
[TBL] [Abstract][Full Text] [Related]
58. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma.
Zhang Z; Su T; He L; Wang H; Ji G; Liu X; Zhang Y; Dong G
Tohoku J Exp Med; 2012 Jan; 226(1):59-68. PubMed ID: 22189020
[TBL] [Abstract][Full Text] [Related]
59. Endothelial cell activation and proliferation modulate NKG2D activity by regulating MICA expression and shedding.
Chauveau A; Tonnerre P; Pabois A; Gavlovsky PJ; Chatelais M; Coupel S; Charreau B
J Innate Immun; 2014; 6(1):89-104. PubMed ID: 23860405
[TBL] [Abstract][Full Text] [Related]
60. MICA-G129R: A bifunctional fusion protein increases PRLR-positive breast cancer cell death in co-culture with natural killer cells.
Ding H; Buzzard GW; Huang S; Sehorn MG; Marcus RK; Wei Y
PLoS One; 2021; 16(6):e0252662. PubMed ID: 34077462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]